- Viveve Medical (NASDAQ:VIVE) +35%.
- Quad/Graphics (NYSE:QUAD) +24% on Q4 results.
- Myomo (NYSEMKT:MYO) +21% on expanded MyoPro access.
- Cemtrex (NASDAQ:CETX) +18% on Q1 results.
- Enphase Energy (NASDAQ:ENPH) +14% on Q4 results.
- Streamline Health Solutions (NASDAQ:STRM) +14%.
- Virgin Galactic Holdings (NYSE:SPCE) +14% on signing deal to fly private citizens into orbit.
- Cytosorbents (NASDAQ:CTSO) +12% on CytoSorb deal in Asia.
- Sequans Communications S.A. (NYSE:SQNS) +10%.
- Fiverr International (NYSE:FVRR) +10% on Q4 results.
- Garmin (NASDAQ:GRMN) +9% on Q4 results.
- Sibanye Gold (NYSE:SBGL) +9% on Q4 results.
- Plug Power (NASDAQ:PLUG) +9%.
- Senseonics Holdings (NYSEMKT:SENS) +7% on new coverage of Eversense.
- Tesla (NASDAQ:TSLA) +7% on positive analyst upgrade.
- Co-Diagnostics (NASDAQ:CODX) +6% on vector control orders, coronavirus test advancement.
- Ballard Power Systems (NASDAQ:BLDP) +6%.
- Analog Devices (NASDAQ:ADI) +6% on Q1 results.
- Xeris Pharmaceuticals (NASDAQ:XERS) +5%.
- Bed Bath & Beyond (NASDAQ:BBBY) +5% as CEO promises big changes.
- Intelsat S.A. (NYSE:I) +5%.
- VIVUS (NASDAQ:VVUS) +5% on Qsymia launch in Korea.